N

NKMax Co Ltd
KOSDAQ:182400

Watchlist Manager
NKMax Co Ltd
KOSDAQ:182400
Watchlist
Price: 2 020 KRW 9.54% Market Closed
Market Cap: 172.7B KRW

Wall Street
Price Targets

Price Targets Summary
NKMax Co Ltd

There are no price targets for NKMax Co Ltd.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
NKMax Co Ltd Competitors:
Price Targets
ORKA
Oruka Therapeutics Inc
58% Upside
CRVO
Diffusion Pharmaceuticals Inc
183% Upside
KNSA
Kiniksa Pharmaceuticals Ltd
33% Upside
6990
Sichuan Kelun-Biotech Biopharmaceutical Co Ltd
29% Upside
FYB
Formycon AG
102% Upside
EDT
Spectral Medical Inc
149% Upside
TWST
Twist Bioscience Corp
19% Upside
1801
Innovent Biologics Inc
33% Upside

Revenue
Forecast

Revenue Estimate
NKMax Co Ltd

For the last 10 years the compound annual growth rate for NKMax Co Ltd's revenue is 18%. The projected CAGR for the next 4 years is 6%.

18%
Past Growth
6%
Estimated Growth
Estimates Accuracy
-19%
Average Miss

Operating Income
Forecast

Operating Income Estimate
NKMax Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
52%
Average Beat

Net Income
Forecast

Net Income Estimate
NKMax Co Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-87%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is NKMax Co Ltd's stock price target?
Not Available

NKMax Co Ltd doesn't have any price targets made by Wall Street professionals.

What is NKMax Co Ltd's Revenue forecast?
Projected CAGR
6%

For the last 10 years the compound annual growth rate for NKMax Co Ltd's revenue is 18%. The projected CAGR for the next 4 years is 6%.

Back to Top